Health

Hong Kong's Hang Fook Elderly Home Adopts iBonus(R) Digital Prevention System Aimed at Helping Guard Against COVID-19

HONG KONG, Aug. 20, 2020 /PRNewswire/ -- One of the key reasons that COVID-19 has caused a great concern is its long incubation period. Most experts agree that for up to 14 days many affected patients have no obvious symptoms. Since nobody knows where these people have been or who they have been ...

2020-08-20 20:35 3340

Ascletis Completed Bridging Study of ASC18, a One-pill, Once-a-day Complete HCV Oral Regimen

HANGZHOU and SHAOXING, China, Aug. 20, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that it completed bridging study of ASC18, first one-pill, once-a-day fixed dose combination (FDC) as the complete hepatitis C treatment developed by a Chinese biotech. ASC18 FDC co...

2020-08-20 20:00 3728

Sihuan Pharmaceutical Introduced Investors for Capital Increase to Accelerate Solid-liquid Double Chamber Infusion Soft Bag Industry

HONG KONG, Aug. 20, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460 "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that Beijing Ruiye Drugs Manufacture Co., Ltd. ("Beijing Ruiye"), an associate of the Grou...

2020-08-20 19:39 13722

Low-Cost Nafamostat Blocks SARS-CoV-2 Infection in Human Lung Cells, Preclinical Study Finds

SAN DIEGO, Aug. 20, 2020 /PRNewswire/ -- A preclinical study testing the low-cost generic drug nafamostat in human cells shows it can help block SARS-CoV-2 infection, raising excitement around Covistat's work to develop prophylactic and therapeutic COVID-19 treatments. Biopharmaceutical company ...

2020-08-20 19:00 2668

LumiraDx Receives FDA Emergency Use Authorization for Point of Care COVID-19 Antigen Test

LONDON, Aug. 20, 2020 /PRNewswire/ -- LumiraDx, the next-generation point of care diagnostic company, announced today that it hasreceived Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the LumiraDx SARS-CoV-2 antigen test, which will help meet the global ch...

2020-08-20 18:00 3812

Zepp Unveils Zepp E, A New Stylish Line-Up of Wearables Designed with Wellness in Mind

SHENZHEN, China, Aug. 20, 2020 /PRNewswire/ -- Zepp, a professional-grade brand for the digital management of users' wellbeing, today unveiled a refreshed line-up of wearables, kicking off with the Zepp E series. With wellbeing at the top of everyone's agenda in 2020, the all-new Zepp E series ha...

2020-08-20 16:00 4645

Visiopharm granted patents for stain quality management in Tissue Biomarkers

HOERSHOLM, Denmark, Aug. 20, 2020 /PRNewswire/ -- Visiopharm®, the Denmark -based leader in artificial intelligence-driven image analysis, tissue mining, and precision pathology, has been granted patents in the US andEurope for an AI and image analysis-based approach to quantifying staining qualit...

2020-08-20 14:00 2386

Zymo Research Granted CE IVD Mark for Quick SARS-CoV-2 rRT-PCR Kit

IRVINE, California, Aug. 20, 2020 /PRNewswire/ -- Zymo Research announced that it was recently granted the CE IVD Mark for itsQuick SARS-CoV-2 rRT-PCR Kit. To obtain this certification the product had to comply with the Directive 98/79/EC of the European Parliament and of the Council of27 October...

2020-08-20 09:35 3583

US FDA Awards Fast Track Designation (FTD) to Paxalisib for Glioblastoma

SYDNEY, Aug. 20, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Kazia's paxalisib (forme...

2020-08-20 08:35 8517

Harbour BioMed, Utrecht University, Erasmus Medical Center, Viroclinics-DDL and Kiadis Pharma Announce Collaboration to Develop Monoclonal Antibody, Natural Killer Cell Combination Approach to Treating COVID-19

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Aug. 19, 2020 /PRNewswire/ -- Harbour BioMed (HBM), and its partnersUtrecht University and Erasmus Medical Center, today announced a new research collaboration with Viroclinics-DDL and Kiadis Pharma (Euronext Amsterdam and Brussels: K...

2020-08-19 19:43 2860

Jamjoom Pharmaceuticals Earns Acclaim from Frost & Sullivan for its Dominance in the KSA Pharma Market with its Expanded Portfolio and Geographic Presence

Jamjoom Pharmaceuticals is dedicated to being a center of excellence in healthcare and providing high-quality, safe, and effective products to meet the regional need JEDDAH, Saudi Arabia, Aug. 19, 2020 /PRNewswire/ -- Based on its recent analysis of the KSA emerging generic pharmaceuticals marke...

2020-08-19 16:00 1907

Global Entertainment Giant YOOZOO Aligns with Health Tech Company Plano to Tackle the Global Myopia Epidemic

SINGAPORE, Aug. 19, 2020 /PRNewswire/ -- Plano Pte Ltd (hereinafter, Plano), a Singapore-based health technology startup, and one of the world's leading providers of interactive entertainment, YOOZOO, have inked a Memorandum of Understanding to address the global burden of myopia inSingapore, the...

2020-08-19 12:00 4301

CStone Pharmaceuticals Reports Financial Results for the First Half of 2020

SUZHOU, China, Aug. 19, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology (IO) therapies and precision medicines, today reported recent business highlights and financial resu...

2020-08-19 09:33 4162

Aon urges the re/insurance industry to bring capital closer to clients' needs as the firm launches its Virtual Reinsurance Renewal Season

Virtual event launches with former Danish Prime Minister Helle Thorning-Schmidt interview LONDON, Aug. 18, 2020 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm providing a broad range of risk, retirement and health solutions, today launches itsVirtual Reinsurance...

2020-08-18 23:37 20576

Mindray Sets A New Standard for Infusion Systems with the BeneFusion n Series

SHENZHEN, China, Aug. 18, 2020 /PRNewswire/ -- Mindray (SZSE: 300760), a leading provider of medical devices and solutions, has released its new generation infusion system,BeneFusion n Series. By rethinking safety, simplicity, interoperability and data synergy, the BeneFusion n Series sets a new...

2020-08-18 21:00 6467

athenahealth Earns the Frost & Sullivan 2020 RCM Company of the Year Award

athenahealth acclaimed by Frost & Sullivan for being at the forefront of solving critical RCM challenges and powering providers with agile solutions during the Covid-19 pandemic SANTA CLARA, California, Aug. 18, 2020 /PRNewswire/ -- Based on its recent analysis ofthe United States revenue cycle ...

2020-08-18 21:00 2499

Ascentage Pharma Releases 2020 Interim Results, Reporting the Company's First New Drug Application and Advances in Global Strategic Collaborations

SUZHOU, China and ROCKVILLE, Md., Aug. 18, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its interim results for the ...

2020-08-18 20:24 3372

Global Cord Blood Corporation to Report First Quarter Fiscal 2021 Financial Results

HONG KONG, Aug. 18, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release financial results fo...

2020-08-18 19:00 11301

Innovent and Lilly Announce Expansion of TYVYT® (Sintilimab Injection) Licensing Agreement

SUZHOU, China and INDIANAPOLIS, Aug. 18, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...

2020-08-18 18:30 6076

Work Health Safety Expert warns Australian companies to be Vigilant.

NEWCASTLE, Australia, Aug. 18, 2020 /PRNewswire/ -- James Prout, CEO of Zokal Safety Australia, issued the following statement: "Australian business owners and directors should evaluate their safety systems and procedures as a matter of urgency," said work health safety specialist James Prout. "...

2020-08-18 07:17 2297
1 ... 435436437438439440441 ... 562